| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.089 | 0.3 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |